106 related articles for article (PubMed ID: 10758065)
1. Is asymmetric dimethylarginine a novel marker of atherosclerosis?
Böger RH; Bode-Böger SM; Matsuoka H; Miyazaki H; Usui M; Ueda S; Okuda S; Imaizumi T; Cooke JP
Circulation; 2000 Apr; 101(14):E160-1. PubMed ID: 10758065
[No Abstract] [Full Text] [Related]
2. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
Circulation; 1999 Mar; 99(9):1141-6. PubMed ID: 10069780
[TBL] [Abstract][Full Text] [Related]
3. [Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis].
Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
J Cardiol; 1999 Feb; 33(2):105-6. PubMed ID: 10087482
[No Abstract] [Full Text] [Related]
4. Possible involvement of enhanced arginase activity due to up-regulated arginases and decreased hydroxyarginine in accelerating intimal hyperplasia with hyperglycemia.
Ishizaka M; Nagai A; Iwanaga M; Imamura M; Azuma H
Vascul Pharmacol; 2007; 47(5-6):272-80. PubMed ID: 17804300
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia.
Lücke T; Tsikas D; Kanzelmeyer N; Vaske B; Das AM
Metabolism; 2006 Dec; 55(12):1599-603. PubMed ID: 17142130
[TBL] [Abstract][Full Text] [Related]
6. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography.
Tsikas D; Junker W; Frölich JC
J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):174-6. PubMed ID: 9498688
[No Abstract] [Full Text] [Related]
7. [Asymmetric dimethil-arginine (ADMA) as a link between insulin resistance and atherosclerosis].
Zsuga J
Ideggyogy Sz; 2008 May; 61(5-6):183-92. PubMed ID: 18567394
[No Abstract] [Full Text] [Related]
8. Increased asymmetric dimethylarginine in vitamin B12 deficient adolescents.
Dündar MA; Torun YA; Çelik SF; Tartıcı EK; Karakükçü Ç
Cardiol Young; 2019 Feb; 29(2):190-194. PubMed ID: 30785385
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine and hypertension in cerebral small vessel disease.
Tsuda K
Stroke; 2007 Jul; 38(7):e48; author reply e49. PubMed ID: 17510451
[No Abstract] [Full Text] [Related]
10. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.
Abbasi F; Asagmi T; Cooke JP; Lamendola C; McLaughlin T; Reaven GM; Stuehlinger M; Tsao PS
Am J Cardiol; 2001 Nov; 88(10):1201-3. PubMed ID: 11703973
[No Abstract] [Full Text] [Related]
11. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis.
Landburg PP; Teerlink T; Muskiet FA; Duits AJ; Schnog JJ;
Am J Hematol; 2008 Jul; 83(7):577-9. PubMed ID: 18383318
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond.
Böger RH
Ann Med; 2006; 38(2):126-36. PubMed ID: 16581698
[TBL] [Abstract][Full Text] [Related]
13. NG-nitro-L-arginine methyl ester does not affect balloon catheter-induced intimal hyperplasia in rats.
Watkins RW; Pula K; Cook J; Hoos L; McLeod R; Prioli NA; Davis HR
Biochem Biophys Res Commun; 1993 Nov; 197(1):304-9. PubMed ID: 7504485
[TBL] [Abstract][Full Text] [Related]
14. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine: clinical applications in pediatric medicine.
Tain YL; Huang LT
J Formos Med Assoc; 2011 Feb; 110(2):70-7. PubMed ID: 21377060
[TBL] [Abstract][Full Text] [Related]
16. Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries.
Loyaga-Rendon RY; Sakamoto S; Beppu M; Aso T; Ishizaka M; Takahashi R; Azuma H
Atherosclerosis; 2005 Feb; 178(2):231-9. PubMed ID: 15694929
[TBL] [Abstract][Full Text] [Related]
17. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox.
Tsikas D; Böger RH; Sandmann J; Bode-Böger SM; Frölich JC
FEBS Lett; 2000 Jul; 478(1-2):1-3. PubMed ID: 10922458
[TBL] [Abstract][Full Text] [Related]
18. Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis.
Zsuga J; Torok J; Magyar MT; Valikovics A; Gesztelyi R; Kéki S; Csiba L; Zsuga M; Bereczki D
Cerebrovasc Dis; 2007; 23(5-6):388-94. PubMed ID: 17406107
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Notsu Y; Nabika T; Bokura H; Suyama Y; Kobayashi S; Yamaguchi S; Masuda J
Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylorginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome.
Verit FF; Vural M
Fertil Steril; 2009 Jul; 92(1):e12; author reply e13. PubMed ID: 19482274
[No Abstract] [Full Text] [Related]
[Next] [New Search]
